2023年6月19日

首次合成生物學——一個垂直整合的公司正在帶頭創建創新和新型高性能活性成分在美- B係列最近宣布,它已經籌集了3400萬美元資金輪由大膽,歐萊雅的風險資本基金,世界領先的美。和其他參與的投資者包括精細結構企業、材料的影響,GS期貨,卡瓦略,Cultivian沙箱,ACVC夥伴等等。作為戰略夥伴關係的一部分,歐萊雅的風險資本基金大膽,首次將開發一個各種各樣的小說成分和美容和個人護理產品使用其專有的顆粒以及生物技術模式,以加速這項技術的商業化在整個美容行業。和首次亮相是唯一的球員在生物技術領域具有完整的垂直整合能力將成分發現,完成clinically-backed可伸縮的成分,和品牌在貨架上,以前所未有的速度交付。係列B與大膽的一輪融資和合作將為首次配備資源快速建立這個新的基準。首次亮相的專有Bio2Consumer平台跨越成分的發現,細胞遊離,biofermentation,製定、臨床試驗和品牌創建。和顆粒以及先進的平台利用發酵方法如連續為克服傳統方法的局限性,極大地減少了需要空間,水,和昂貴的和不可持續的投入。隨著生產罕見、高價值和新穎的化合物,首次傳統成分製造的技術也得到了提高。平台包含專有的數據庫超過380萬臨床前數據點查找和發現新的成分,滿足美容消費需求。首次通過克服細胞發酵的局限性,能夠生產高附加值成分迅速和更可持續。 The company’s portfolio of ingredients is both natural and lab-made, comprising the best of both worlds and protecting the environment from resource extraction. And Debut’s inputs into the biomanufacturing process are found in nature. The enzymes used for catalyzing the transformation to high-value natural products are also found in nature. Debut’s $22.6 million Series A in August 2021 (led by Material Impact) helped scale its unique and unprecedented ingredient development model, establish its in-house brand incubator, and grow into its 26,000-square-foot facility in San Diego. KEY QUOTES: “Debut exists to set a new standard in beauty by developing novel active ingredients that herald a new era with regard to performance, sustainability, scalability, and cost, and we are thrilled to be partnering with L’Oréal’s BOLD, the beauty world leader that is as invested in this industry’s future as we are. Every day, we are leveraging our team’s groundbreaking technology, scientific research, and unbridled creativity to lead the biological revolution that will transform beauty as we know it. We harness synthetic biology to create novel and higher-performing ingredients that are not accessible by other means in order to advance product benefits and target unmet consumer needs.” “What science allows us to do is understand how nature makes it, and then translate that to an industrially scalable system to provide the exact same molecules that are found in trace amounts in nature using synthetic biology.” — Debut Founder and CEO Joshua Britton, Ph.D. “Debut addresses one of the beauty world’s fundamental challenges: driving innovation without the resource-intensity and environmental impact that comes with relying on traditional manufacturing alone. Cell-free biomanufacturing is not science fiction: it is here. We could not be more excited to be the first beauty leader to invest in Debut and partner with them to create stand-out active beauty innovations while protecting the planet’s resources.” — Barbara Lavernos, Deputy Chief Executive Officer in charge of Research, Innovation and Technology, at L’Oréal Trending on Pulse 2.0